Global Patent Index - EP 4096629 A1

EP 4096629 A1 20221207 - BUTYRIC ACID SALT-BASED COMPOSITION FOR RECTAL APPLICATION FOR THE TREATMENT OF PROCTOLOGY DISORDERS

Title (en)

BUTYRIC ACID SALT-BASED COMPOSITION FOR RECTAL APPLICATION FOR THE TREATMENT OF PROCTOLOGY DISORDERS

Title (de)

AUF BUTTERSÄURESALZ BASIERENDE ZUSAMMENSETZUNG ZUR REKTALEN ANWENDUNG ZUR BEHANDLUNG VON PROCTOLOGIESTÖRUNGEN

Title (fr)

COMPOSITION À BASE DE SEL D'ACIDE BUTYRIQUE POUR APPLICATION RECTALE POUR LE TRAITEMENT DE TROUBLES PROCTOLOGIQUES

Publication

EP 4096629 A1 20221207 (EN)

Application

EP 21708364 A 20210128

Priority

  • IT 202000001831 A 20200130
  • IB 2021050659 W 20210128

Abstract (en)

[origin: WO2021152492A1] A water-based composition for use in the rectal treatment of proctological disorders comprising sodium hyaluronate butyrate and a polymer compound belonging to the polysiloxane family and having a nominal viscosity ranging from 200 to 500 mm2/s. The weight ratio between sodium hyaluronate butyrate and the polymer compound ranges from 0.01 to 0.1.

IPC 8 full level

A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 31/728 (2006.01); A61K 47/34 (2017.01); A61P 9/14 (2006.01)

CPC (source: EP)

A61K 9/0031 (2013.01); A61K 9/107 (2013.01); A61K 31/728 (2013.01); A61K 47/34 (2013.01); A61P 9/14 (2017.12)

Citation (search report)

See references of WO 2021152492A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

Designated extension state (EPC)

BA ME

Designated validation state (EPC)

KH MA MD TN

DOCDB simple family (publication)

WO 2021152492 A1 20210805; EP 4096629 A1 20221207; IT 202000001831 A1 20210730

DOCDB simple family (application)

IB 2021050659 W 20210128; EP 21708364 A 20210128; IT 202000001831 A 20200130